PRF Technologies Ltd. (PRFX) shareholders
PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.78−0.00 (-0.53%)
Close on Nov 13, 2026Market cap $650.04KP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
24.5%
0M of 1M shares
Institutional holders
8
4 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Medica III Management Co. Joint filing with Medica III Management L.P. (19.85%), Medica III Investments (International) L.P. (19.85%) and 7 more | 346,478 | 19.85% | 13G (passive) amendment | Dec 31, 2023 |
| Yorkville Advisors Global, LP Joint filing with YA II PN, Ltd. (9.99%), YA Global Investments II (U.S.), LP (9.99%) and 5 more | 333,105 | 9.99% | 13G (passive) amendment | Jun 18, 2026 |
| S.H.N. Financial Investments Ltd. | 200,000 | 5.72% | 13D (active) amendment | Nov 2, 2026 |
| XT Hi-Tech Investments (1992) Ltd Joint filing with XT Holdings Ltd. (5.20%) | 106,588 | 5.20% | 13G (passive) amendment | Dec 31, 2023 |
| YA II PN, Ltd. Joint filing with YA Global Investments II (U.S.), LP (9.99%), Yorkville Advisors Global, LP (9.99%) and 5 more | 66,625 | 9.99% | 13G (passive) | May 7, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PRFX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 81,103 | 9.76% | $111.92K | New | 0.13% |
| Jane Street Group, LLC | 80,387 | 9.68% | $110.93K | New | 0.00% |
| Citadel Advisors LLC | 28,575 | 3.44% | $39.43K | +15,355 | 0.00% |
| UBS Group AG | 10,415 | 1.25% | $14.37K | +9,546 | 0.00% |
| Morgan Stanley | 2,783 | 0.34% | $3.84K | +1,172 | 0.00% |
| Royal Bank of Canada | 233 | 0.03% | $0 | New | 0.00% |
| Osaic Holdings, Inc. | 40 | 0.00% | $53 | – | 0.00% |
| Rockefeller Capital Management L.P. | 1 | 0.00% | $1 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 24.5% | 4 / 3 | 0 / 0 | 0M | 0M |
| Q1 2026 | 4 | 0M | 1.9% | 1 / 2 | 1 / 3 | 0M | 0M |
| Q4 2025 | 6 | 0M | 1.6% | 2 / 2 | 0 / 0 | 0M | 0M |
| Q3 2025 | 4 | 0M | 0.4% | 1 / 0 | 1 / 1 | 0M | 0M |
| Q2 2025 | 4 | 0M | 0.5% | 2 / 0 | 0 / 1 | 0M | 0M |
| Q1 2025 | 3 | 0M | 0.0% | 1 / 0 | 0 / 4 | 0M | 0M |
| Q4 2024 | 6 | 0M | 1.0% | 6 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Efraim Cohen-Arazi | Interim CEO, Director | – | – | Mar 18, 2026 |
| Ehud Geller | Exec Chairman of the Board, Director | – | – | Mar 18, 2026 |
| Eyal Broder | Chief Financial Officer | – | – | Mar 18, 2026 |
| Sigal Aviel | Chief Operating Officer | – | – | Mar 18, 2026 |
| Asaf Shavit | Director | – | – | Mar 18, 2026 |
| Ellen S. Baron | Director | – | – | Mar 18, 2026 |
| Augustine Lawlor | Director | – | – | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
2.03%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-35.9%
From 0M shares
Short volume, 20 days
37.9%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of PRF Technologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 115,487 shares on Sep 17, 2026 over the last 90 days.
See a number that looks wrong?